03/31/2025
4:15 PM | Matinas Biopharma (Filer)
| Form NT 10-K | |
03/17/2025
4:30 PM | Matinas Biopharma (Issuer)
NEUGEBOREN EDWARD (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
03/17/2025
4:30 PM | Matinas Biopharma (Issuer)
Murphy Keith (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
03/14/2025
4:20 PM | Matinas Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/11/2025
6:01 AM | Matinas Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/07/2025
5:35 PM | EIDE ROBERT J (Reporting)
Matinas Biopharma (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
03/03/2025
4:25 PM | Matinas Biopharma (Filer)
| Form DEF 14A | |
02/28/2025
3:58 PM | Matinas Biopharma (Issuer)
Sanitam Partners LLC (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
02/25/2025
5:35 PM | Matinas Biopharma (Issuer)
Pembroke & Partners LLC (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
02/21/2025
4:15 PM | Matinas Biopharma (Filer)
| Form PRE 14A | |
02/21/2025
2:07 PM | Matinas Biopharma (Subject)
Sanitam Partners LLC (Filed by)
| Form SCHEDULE 13D | |
Get the Latest News and Ratings for MTNB and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Matinas Biopharma and its competitors with MarketBeat's FREE daily newsletter. |
02/21/2025
2:11 PM | Matinas Biopharma (Subject)
Pembroke & Partners LLC (Filed by)
| Form SCHEDULE 13D | |
02/19/2025
3:05 PM | Matinas Biopharma (Filer)
| Form D
Notice of Exempt Offering of Securities | |
02/19/2025
1:22 PM | 111 Equity Group (Filed by)
Matinas Biopharma (Subject)
| Form SCHEDULE 13D/A | |
02/13/2025
5:00 PM | Matinas Biopharma (Issuer)
Smith Robin L (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
02/13/2025
4:20 PM | Matinas Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/07/2025
4:00 PM | D An Evelyn (Reporting)
Matinas Biopharma (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
02/07/2025
6:30 AM | Matinas Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/24/2025
4:15 PM | Matinas Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/10/2025
4:15 PM | Matinas Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/13/2024
4:16 PM | Matinas Biopharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/31/2024
5:31 AM | Matinas Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/25/2024
8:15 AM | HIGHBRIDGE CAPITAL MANAGEMENT LLC (Filed by)
Matinas Biopharma (Subject)
| Form SC 13G | |
09/03/2024
7:56 AM | Matinas Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/27/2024
8:39 PM | Matinas Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/09/2024
3:06 PM | Matinas Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/05/2024
6:00 AM | Matinas Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/04/2024
3:15 PM | Matinas Biopharma (Filer)
| Form 424B5 | |
